FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Regeneron (NASDAQ: REGN) | Delayed: 816.10 +8.43 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $807.67 | 52 Week High | $592.36 | |||
| Open | $807.67 | 52 Week Low | $325.35 | |||
| Day High | $816.14 | P/E | 214.20 | |||
| Day Low | $804.05 | EPS | $3.81 | |||
| Volume | 726,152 | |||||
